The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 3
- 3 renewals
- Median first-year cost
- $1,000,000
- $3,038,227 in all
- Institutions
- 3
- 3 contact PIs
- Patents
- 30
- from 2 funded projects
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- DELPHINUS MEDICAL TECHNOLOGIES, INC.1
- IMAGINAB, INC.1
- PRESAGE BIOSCIENCES, INC.1
Most frequent study sections
- Special Emphasis Panel (ZCA1 TCRB-9 (O3))3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2016 | Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma2R44CA144104-04 | Klinghoffer, RichardOlson, James M | PRESAGE BIOSCIENCES, INC., WA | First-year cost $1,053,521 | Study section ZCA1 |
| FY2016 | Clinical Development of a Novel PET Imaging Agent for Prostate Cancer2R44CA192927-04A1 | Mascioni, Alessandro | IMAGINAB, INC., CA | First-year cost $1,000,000 | Study section ZCA1 |
| FY2016 | Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.2R44CA165320-04 | Duric, Nebojsa | DELPHINUS MEDICAL TECHNOLOGIES, INC., MI | First-year cost $984,706 | Study section ZCA1 |
Patents from its funded projects
30 patents name 2 of the 3 funded projects. The newest 5, by patent number.
- US 12,161,505 (opens the patent at USPTO, a PDF, in a new tab)PATIENT INTERFACE SYSTEMGranted December 10, 2024 to Delphinus Medical Technologies, Inc.R44CA165320 · DELPHINUS MEDICAL TECHNOLOGIES, INC., MI
- US 11,399,798 (opens the patent at USPTO, a PDF, in a new tab)METHOD OF CHARACTERIZING TISSUE OF A PATIENTGranted August 2, 2022 to Delphinus Medical Technologies, Inc.R44CA165320 · DELPHINUS MEDICAL TECHNOLOGIES, INC., MI
- US 11,298,111 (opens the patent at USPTO, a PDF, in a new tab)METHOD FOR GENERATING AN ENHANCED IMAGE OF A VOLUME OF TISSUEGranted April 12, 2022 to Delphinus Medical Technologies, Inc.R44CA165320 · DELPHINUS MEDICAL TECHNOLOGIES, INC., MI
- US 11,147,537 (opens the patent at USPTO, a PDF, in a new tab)Method for Representing Tissue StiffnessGranted October 19, 2021 to Delphinus Medical Technologies, Inc.R44CA165320 · DELPHINUS MEDICAL TECHNOLOGIES, INC., MI
- US 11,064,974 (opens the patent at USPTO, a PDF, in a new tab)Patient Interface SystemGranted July 20, 2021 to Delphinus Medical Technologies, Inc.R44CA165320 · DELPHINUS MEDICAL TECHNOLOGIES, INC., MI
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.